跳至主要内容
临床试验/NCT06755307
NCT06755307招募中不适用

PROBIOTICS FOR TREATING DIAPER DERMATITIS IN CHILDREN - A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED CLINICAL TRIAL

University Maribor2 个研究点 分布在 1 个国家目标入组 42 人开始时间: 2025年8月14日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
42
试验地点
2
主要终点
Duration of diaper dermatis

研究概览

简要总结

The goal of this randomized controlled clinical trial is to determine the effect of the probiotic OMNiBiOTiC® Panda in treating diaper dermatitis in children under the age of two years. The main question it aims to answer is:

Is the probiotic OMNiBiOTiC® Panda effective in reducing the duration of diaper dermatitis in children under the age of two years?

Researchers will compare the probiotic and placebo group to see if the duration of diaper dermatitis is significant among the two groups.

Participants will:

  • receive 6 droplets daily of probiotic or placebo for 3 weeks and
  • observe and record improvement of diaper rash symptoms each day using a diary.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
1 Month 至 2 Years(Child)
性别
All
接受健康志愿者

入选标准

  • presence of diaper dermatitis
  • age less than two years

排除标准

  • previous use of probiotics
  • age more than two years
  • an acute bacterial infection
  • chronic disease
  • local use of antibiotics in the anogenital region

结局指标

主要结局

Duration of diaper dermatis

时间窗: 3 weeks supplementation

Comparison of the duration of diaper dermatitis in children younger than two years in both arms via daily the use of the diary.

次要结局

未报告次要终点

研究者

发起方
University Maribor
申办方类型
Other
责任方
Principal Investigator
主要研究者

Sabina Fijan

Assoc. Prof. Dr.

University Maribor

研究点 (2)

Loading locations...

相似试验